Apoptosis detection for non-adherent cells in time-lapse phase contrast microscopy.

Med Image Comput Comput Assist Interv

Lane Center for Computational Biology and Robotics Institute, Carnegie Mellon University, USA.

Published: April 2014

This paper proposes a vision-based method for detecting apoptosis (programmed cell death), which is essential for non-perturbative monitoring of cell expansion. Our method targets non-adherent cells, which float or are suspended freely in the culture medium-in contrast to adherent cells, which are attached to a petri dish. The method first detects cell regions and tracks them over time, resulting in the construction of cell tracklets. For each of the tracklets, visual properties of the cell are then examined to know whether and when the tracklet shows a transition from a live cell to a dead cell, in order to determine the occurrence and timing of a cell death event. For the validation, a transductive learning framework is adopted to utilize unlabeled data in addition to labeled data. Our method achieved promising performance in the experiments with hematopoietic stem cell (HSC) populations, which are currently in clinical use for rescuing hematopoietic function during bone marrow transplants.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-40763-5_8DOI Listing

Publication Analysis

Top Keywords

cell
9
non-adherent cells
8
cell death
8
apoptosis detection
4
detection non-adherent
4
cells time-lapse
4
time-lapse phase
4
phase contrast
4
contrast microscopy
4
microscopy paper
4

Similar Publications

Metabolic syndrome-related diseases frequently involve disturbances in skeletal muscle lipid metabolism. The accumulation of lipid metabolites, lipid-induced mitochondrial stress in skeletal muscle cells, as well as the inflammation of adjacent adipose tissue, are associated with the development of insulin resistance and metabolic dysfunction. Consequently, when antidiabetic medications are used to treat various chronic conditions related to hyperglycaemia, the impact on skeletal muscle lipid metabolism should not be overlooked.

View Article and Find Full Text PDF

The histologic differential diagnosis between intracranial hemangioblastoma (HB) and metastatic clear cell renal cell carcinoma may be challenging, especially considering that both tumors exhibit clear cell morphology and can be associated with vHL mutation and/or Von Hippel-Lindau syndrome. As the execution of immunohistochemical analyses is often mandatory, the expression of PAX8 has been traditionally considered a reliable marker of metastatic clear cell renal cell carcinoma, being consistently negative in intracranial HB. However, as in recent years, some cases of PAX8-positive HBs have been reported in the literature; we studied the expression of this antibody on a series of 23 intracranial HB, showing that about 40% of these tumors may express PAX8 and that this immunoreactivity is often focal and weak.

View Article and Find Full Text PDF

Glucose Transporter 1 Deficiency Impairs Glucose Metabolism and Barrier Induction in Human Induced Pluripotent Stem Cell-Derived Astrocytes.

J Cell Physiol

January 2025

Department of Pharmaceutical Sciences and Center for Blood-Brain Barrier Research, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, USA.

Glucose is a major source of energy for the brain. At the blood-brain barrier (BBB), glucose uptake is facilitated by glucose transporter 1 (GLUT1). GLUT1 Deficiency Syndrome (GLUT1DS), a haploinsufficiency affecting SLC2A1, reduces glucose brain uptake.

View Article and Find Full Text PDF

Background: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma (RCC). Due to the lack of symptoms until advanced stages, early diagnosis of ccRCC is challenging. Therefore, the identification of novel secreted biomarkers for the early detection of ccRCC is urgently needed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!